Internal Medicine, Endocrinology, Diabetes, & Metabolism · Baltimore, MD
NPI
1063444529
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
600 N Wolfe St
Baltimore, MD, 21287
Phone (410) 955-9270
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
359 services
Medicare patients, 2024
280
Average age 70
Drug cost, 2024
$1.1M
1,267 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto Salvatori was code 99214 (office e&m - established), 87 times for 79 patients. In total Roberto Salvatori billed 359 services in 18 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 87 | 79 | $69.90 | $6,081 |
| 99213 Office E&M - Established | Facility | 68 | 61 | $45.18 | $3,072 |
| 99204 Office E&M - New | Facility | 39 | 39 | $99.71 | $3,889 |
| 99205 Office E&M - New | Facility | 31 | 31 | $120.72 | $3,742 |
| 99213 Office E&M - Established | Office | 29 | 27 | $66.30 | $1,923 |
| 99215 Office E&M - Established | Facility | 19 | 19 | $95.38 | $1,812 |
| 99212 Office E&M - Established | Office | 16 | 16 | $38.96 | $623 |
By year: 2022 $29K for 329 services; 2023 $24K for 306 services; 2024 $25K for 359 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roberto Salvatori prescribed most often to Medicare patients was Levothyroxine Sodium, with 364 prescriptions and refills. In total Roberto Salvatori wrote 1,267 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 364 | 840 | 87 | $4,352 |
| Hydrocortisone Generic | 188 | 475 | 52 | $13K |
| Cabergoline Generic | 114 | 281 | 35 | $6,019 |
| Desmopressin Acetate Generic | 81 | 177 | 20 | $15K |
| Testosterone Generic | 69 | 167 | 28 | $21K |
| Genotropin Somatropin | 52 | 68 | Under 11 | $95K |
| Testosterone Cypionate Generic | 52 | 109 | 18 | $1,882 |
| Prednisone Generic | 50 | 122 | 14 | $366 |
| Synthroid Levothyroxine Sodium | 25 | 73 | Under 11 | $912 |
| Xyosted Testosterone Enanthate | 21 | 29 | Under 11 | $17K |
| Fludrocortisone Acetate Generic | 20 | 58 | Under 11 | $566 |
| Omnitrope Somatropin | 15 | 22 | Under 11 | $23K |
| Alendronate Sodium Generic | 15 | 31 | Under 11 | $48.45 |
| Somatuline Depot Lanreotide Acetate | 14 | 14 | Under 11 | $91K |
| Desmopressin Acetate Desmopressin (Nonrefrigerated) | 13 | 24 | Under 11 | $2,729 |
Brand drugs: 392 claims; generic drugs: 852 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto Salvatori $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.